Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of ...

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

A spokesperson for the Cholangiocarcinoma Foundation writes that experimental cancer trials saved her life and could save the ...

Turnstone, which went public via an $80 million IPO in 2023, ended September 2024 with $45.3 million to hand, which the ...

Iovance Biotherapeutics (IOVA -0.96%), a small-cap biotech company, has an innovative approach to treating cancer that relies ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Their oncologists are clamoring for more treatment options for patients who don't respond well to standard care. Amtagvi is ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

Lunit offers free AI biomarker services to SITC researchers for immuno-oncology studies Global researchers gain access to ...

Lunit and SITC collaborate to offer SITC members exclusive access to Lunit SCOPE IO for AI-driven tumor microenvironment analysis. SITC is the world's leading member-driven organization specifically ...

San Diego, USA-based Turnstone Biologics yesterday announced that it has completed an assessment of its business and ...